306 results on '"Feldman, Michael"'
Search Results
2. Preresidency research output among US neurological surgery residents.
- Author
-
Gupta, Rishabh, Chen, Jeffrey, Roth, Steven, Kamal, Naveed, Reisen, Breanne, Ortiz, Alexander, Feldman, Michael, Mummareddy, Nishit, Jo, Jacob, and Chambless, Lola
- Published
- 2024
- Full Text
- View/download PDF
3. Clinically Significant Outcome Scores in Orthopaedic Sports Medicine Shoulder and Knee Surgery Are Increasing in Prevalence but Often Reported Incorrectly.
- Author
-
Son, Michelle M., Abbas, Mohammed, Tatusko, Megan, Winkel, Trenton, Barton, Dane, Manoharan, Aditya, and Feldman, Michael D.
- Abstract
To study the prevalence and quality of application of minimal clinically important difference (MCID), substantial clinical benefit (SCB), patient-acceptable symptomatic state (PASS), and maximum outcome improvement (MOI), reported in the orthopaedic sports medicine knee and shoulder literature in recent years and to bring awareness of proper use of such metrics. A literature review of all shoulder and knee articles published from the American Journal of Sports Medicine (AJSM), Journal of Shoulder and Elbow Surgery (JSES), and Arthroscopy from 2016 to 2020 was performed, specifically investigating whether MCID, SCB, PASS, or MOI were used or reported. Additionally, the way these metrics were reported and interpreted was recorded. Out of 5,039 studies, 889 shoulder and knee studies met the inclusion criteria. Overall, 16.7% reported either MCID, PASS, or SCB. MCID was the most reported across all 3 journals. MCID was reported 12.4% of the time throughout the 5 years. PASS was reported 3.2% and SCB 1.1% of the time over the 5 years. MOI was not reported by any of the journals during this period. There was a statistically significant increase in MCID reporting in 2 of the 3 journals over the 5-year course, Arthroscopy (P =.02) and AJSM (P =.05). There was no statistically significant increase in PASS or SCB reporting rates in all 3 journals. Only 39.1% of studies reported MCID correctly (i.e., defined as the number of individual patients meeting MCID/total patients in the study). This study shows an increasing trend in the use of clinically significant outcome metrics, such as MCID, for interpretation of patient-reported outcomes; however, these individual metrics are often not being used on the individual level and subsequently not reported accurately. We recommend determining whether the specific metric met the threshold per individual patient and then reporting those as a percentage of the sample population to achieve the full potential of these metrics and translate them accurately across various studies. As the usage of clinically significant outcome metrics rises, so does the need for accurate reporting. These findings will encourage future studies to follow a more standardized format. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Adjusting the distance
- Author
-
Feldman, Michael
- Abstract
ABSTRACTThis paper describes the anxiety evoked in a patient threatened by invasion or engulfment by his object on the one hand, and the fears of isolation and abandonment on the other. The author illustrates the patient's strugles to find a distance between himself and his object he can tolerate. The analyst has also to cope with the anxieties evoked by the patient's projections, and find a distance between himself and his patient that enables him to think and work.
- Published
- 2024
- Full Text
- View/download PDF
5. Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma
- Author
-
Jubran, Jubran H, Luong, Hanna, Naik, Anant, Srinivasan, Visish M, Ramasubramanian, Aparna, Li, Amanda, Scherschinski, Lea, Feldman, Michael J, Albuquerque, Felipe C, and Abruzzo, Todd A
- Abstract
BackgroundMelphalan, which is poorly soluble at room temperature, is widely used for the treatment of retinoblastoma by selective ophthalmic artery infusion. Evomela, a propylene glycol-free formulation of melphalan with improved solubility and stability, has recently been used as an alternative.To compare the safety and efficacy of Evomela with standard-formulation melphalan (SFM) in the treatment of retinoblastoma by selective ophthalmic artery infusion.MethodsWe performed a retrospective case–control study of patients with retinoblastoma undergoing selective ophthalmic artery infusion with SFM or Evomela at a single institution. Cycle-specific percent tumor regression (CSPTR) was estimated by comparing photos obtained during pretreatment examination under anesthesia (EUA) with those obtained during post-treatment EUA 3–4 weeks later. CSPTR, ocular salvage rates, complication rates, operation times (unadjusted and adjusted for difficulty of ophthalmic artery catheterization), and intraprocedural dose expiration rates were compared between Evomela- and SFM-treated groups. Univariate and multivariate analyses were performed.ResultsNinety-seven operations (melphalan: 45; Evomela: 52) for 23 patients with 27 retinoblastomas were studied. The ocular salvage rate was 79% in the SFM-treated group and 69% in the Evomela-treated group. Multivariate regression controlling for tumor grade, patient age, and treatment history revealed no significant differences in ocular salvage rate, CSPTR, complication rates, or operation times. Although the dose expiration rate was higher for the SFM-treated group, the difference was not statistically significant. Notably, there were no ocular or cerebral ischemic complications.ConclusionEvomela has non-inferior safety and efficacy relative to SFM when used for the treatment of retinoblastoma by selective ophthalmic artery infusion.
- Published
- 2024
- Full Text
- View/download PDF
6. Outcomes in Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Patients Treated With a Medicine-Led Multidisciplinary Approach
- Author
-
Lewcun, Joseph A, Vagonis, Alex, Kontzias, Christina, Newsom, Megan, Drake, Mack, and Feldman, Michael J
- Abstract
Patients with Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have traditionally been treated in burn centers. Our burn center’s approach differs by admitting these patients to a medicine service, with support from the burn team. The aim of this study was to determine whether SJS/TEN patients cared for with our system, with burn involvement but not burn admission, demonstrate equivalent outcomes. We conducted a retrospective review of all SJS/TEN patients admitted to the medicine service at a single academic medical center from 2009 to 2021. Outcome measures such as mortality, length of ICU stay, and total length of hospitalization were collected. The Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN) was used to calculate expected mortality rates within the cohort. The observed mortality rates were then compared to the expected mortality rates. One hundred and twenty-six patients who were admitted for SJS/TEN were included (70 SJS, 40 SJS/TEN overlap, 16 TEN). The mortality rate for the entire cohort was 10.32% as compared to a 22.33% expected mortality rate (P= .010). The observed and expected mortality rates for SJS, SJS/TEN overlap, and TEN subgroups were 1.43% observed versus 10.22% expected (P= .029), 20.00% observed versus 35.83% expected (P= .133), and 25.00% observed version 44.06% expected (P= .264), respectively. Mortality rates in SJS/TEN patients admitted to medicine units are equivalent or decreased as compared to SCORTEN-predicted mortality rates. Admission of SJS/TEN patients to a medicine unit is appropriate providing there is burn team involvement in their care.
- Published
- 2024
- Full Text
- View/download PDF
7. STAT3 mutation-associated airway epithelial defects in Job syndrome.
- Author
-
Zhang, Yihan, Lin, Tian, Leung, Hui Min, Zhang, Cheng, Wilson-Mifsud, Brittany, Feldman, Michael B., Puel, Anne, Lanternier, Fanny, Couderc, Louis-Jean, Danion, Francois, Catherinot, Emilie, Salvator, Hélène, Tcherkian, Colas, Givel, Claire, Xu, Jie, Tearney, Guillermo J., Vyas, Jatin M., Li, Hu, Hurley, Bryan P., and Mou, Hongmei
- Abstract
Job syndrome is a disease of autosomal dominant hyper-IgE syndrome (AD-HIES). Patients harboring STAT3 mutation are particularly prone to airway remodeling and airway infections. Airway epithelial cells play a central role as the first line of defense against pathogenic infection and express high levels of STAT3. This study thus interrogates how AD-HIES STAT3 mutations impact the physiological functions of airway epithelial cells. This study created human airway basal cells expressing 4 common AD-HIES STAT3 mutants (R382W, V463del, V637M, and Y657S). In addition, primary airway epithelial cells were isolated from a patient with Job syndrome who was harboring a STAT3-S560del mutation and from mice harboring a STAT3-V463del mutation. Cell proliferation, differentiation, barrier function, bacterial elimination, and innate immune responses to pathogenic infection were quantitatively analyzed. STAT3 mutations reduce STAT3 protein phosphorylation, nuclear translocation, transcription activity, and protein stability in airway basal cells. As a consequence, STAT3-mutated airway basal cells give rise to airway epithelial cells with abnormal cellular composition and loss of coordinated mucociliary clearance. Notably, AD-HIES STAT3 airway epithelial cells are defective in bacterial killing and fail to initiate vigorous proinflammatory responses and neutrophil transepithelial migration in response to an experimental model of Pseudomonas aeruginosa infection. AD-HIES STAT3 mutations confer numerous abnormalities to airway epithelial cells in cell differentiation and host innate immunity, emphasizing their involvement in the pathogenesis of lung complications in Job syndrome. Therefore, therapies must address the epithelial defects as well as the previously noted immune cell defects to alleviate chronic infections in patients with Job syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Carbon Monoxide-Related Vision Loss in an Acute Burn Patient
- Author
-
Setia, Karishma, Newsom, Megan, Hashimi, Habiba, Collins, Jay, Senthil-Kumar, Prabhu, and Feldman, Michael J
- Abstract
Carbon monoxide poisoning can occur as part of smoke exposure in the burn population. Here we report the case of a 32-year-old, previously healthy male, with carbon monoxide-related blindness after smoke exposure in an apartment fire. Cerebral hypoperfusion was diagnosed using magnetic resonance imaging of the brain, and the patient was diagnosed with cortical visual impairment. He was treated with hyperbaric oxygen therapy following which he had partial recovery of his vision. There is a paucity of information regarding this phenomenon and its treatment.
- Published
- 2024
- Full Text
- View/download PDF
9. Trends in utilization of standardized letters of recommendation in the 2021-2022 neurosurgery application process.
- Author
-
Feldman, Michael J., Ortiz, Alexander V., Roth, Steven G., Dambrino IV, Robert J., Yengo-Kahn, Aaron M., Chitale, Rohan V., and Chambless, Lola B.
- Published
- 2023
- Full Text
- View/download PDF
10. Words matter: using natural language processing to predict neurosurgical residency match outcomes.
- Author
-
Ortiz, Alexander V., Feldman, Michael J., Yengo-Kahn, Aaron M., Roth, Steven G., Dambrino, Robert J., Chitale, Rohan V., and Chambless, Lola B.
- Published
- 2023
- Full Text
- View/download PDF
11. Race as a factor in adverse outcomes following unruptured aneurysm surgery.
- Author
-
Koester, Stefan, Zeoli, Tyler, Yengo-Kahn, Aaron, Feldman, Michael, Lan, Matt, Sweeting, Raeshell, and Chitale, Rohan
- Abstract
• Patients of marginalized racial groups experience lower odds of being electively admitted compared to White patients. • Black patients have an increased likelihood of poorer outcomes and increased length of stay for UIA compared to White patients. • Rates of in-hospital complications were not significantly different between races. Strong evidence demonstrates that race is associated with health outcomes. Previous neurosurgical research has focused predominantly on subjective data, such as patient satisfaction. Our objective was to assess whether racial disparities are present in primary objective outcomes for treatment of intracranial, unruptured aneurysms in the United States. Data from the 2012–2015 National Inpatient Sample (NIS) database was analyzed. Patients who underwent either open or endovascular treatment of unruptured intracranial aneurysms were included (n = 11663). Patients were stratified by race, and those of unknown race or whose race sample size was too underpowered for analysis were excluded (n = 1202), along with those who experienced head trauma (n = 110) or concurrent AVM (n = 71). Poor outcome was defined as in-hospital mortality, discharge to a nursing facility or hospice, placement of a tracheostomy tube, or placement of a gastrostomy tube. The associations between race and adverse outcomes were determined through multivariate logistic regression, corrected for potentially confounding variables such as age, sex, procedural type, elective procedure, obesity, diabetes, tobacco, severity of illness, and hospital type. 7478 White, 1460 Black, 1086 Hispanic, and 279 Asian patients were included in the final analysis. Complication rates were not significantly different between races, however Black patients experienced the highest proportion of complications (24 %). After adjusting for confounders, the odds of poor outcomes were significantly higher for Black patients (OR = 1.32 95 % CI: 1.07–1.62; p = 0.008) when compared to White patients. Black and Hispanic patients demonstrated a longer length of stay (Black, B: 0.04; 95 % CI: 0.03, 0.06; p < 0.001; Hispanic, B: 0.04; 95 % CI: 0.02, 0.05; p < 0.001) when compared to White patients. Our nationwide analysis using the NIS suggests that Black patients treated for unruptured intracranial aneurysms experience worse outcomes and longer lengths of stay when compared to White patients. Recognizing the differences in objective outcomes and the presence of neurosurgical healthcare disparities is an important first step in providing equitable care to all patients. Future studies that carefully follow the social determinants of health and consider more confounding factors in the association between outcomes and determinants are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Neurosurgery Operating Room Efficiency During the COVID-19 Era.
- Author
-
Koester, Stefan W., Jagasia, Puja, Liles, Campbell, Dambrino IV, Robert J., Feldman, Michael, Mathews, Letha, Tiwari, Vikram, and Chambless, Lola
- Published
- 2022
- Full Text
- View/download PDF
13. Biopsy and surgical specimen specific deep learning models for prostate cancer detection on digitized pathology images
- Author
-
Tomaszewski, John E., Ward, Aaron D., Flannery, Brennan T., Lal, Priti, Feldman, Michael D., Natalizio, María, Santa-Rosario, Juan C., and Madabhushi, Anant
- Published
- 2023
- Full Text
- View/download PDF
14. Oral health and functional outcomes following mechanical thrombectomy for ischemic stroke
- Author
-
Feldman, Michael J, Koester, Stefan W, Chaliff, Ryan S, Yengo-Kahn, Aaron, Wong, Gunther, Roth, Steven, Longo, Michael, Fusco, Matthew R, Froehler, Michael T, and Chitale, Rohan
- Abstract
BackgroundAn association between poor dentition and the risk of ischemic stroke has previously been reported in the literature. In this study we assessed oral hygiene (OH), including tooth loss and the presence of dental disease, to determine if an association exists with functional outcomes following mechanical thrombectomy (MT) for large-vessel ischemic stroke.MethodsA retrospective review was conducted of consecutive adult patients at a single comprehensive stroke center who underwent MT from 2012 to 2018. Inclusion criteria included availability of CT imaging to radiographically assess OH. A multivariate analysis was performed, with the primary outcome being 90-day post-thrombectomy modified Rankin Scale (mRS) score >2.ResultsA total of 276 patients met the inclusion criteria. The average number of missing teeth was significantly higher in patients with a poor functional outcome (mean (SD) 10 (11) vs 4 (6), p<0.001). The presence of dental disease was associated with poor functional outcome, including cavities (21 (27%) vs 13 (8%), p<0.001), periapical infection (18 (23%) vs 11 (6.7%), p<0.001), and bone loss (27 (35%) vs 11 (6.7%), p<0.001). Unadjusted, missing teeth was a univariate predictor of poor outcome (OR 1.09 (95% CI 1.06 to 1.13), p<0.001). After adjustment for recanalization scores and use of tissue plasminogen activator (tPA), missing teeth remained a predictor of poor outcome (OR 1.07 (95% CI 1.03 to 1.11), p<0.001).ConclusionMissing teeth and the presence of dental disease are inversely correlated with functional independence following MT, independent of thrombectomy success or tPA status.
- Published
- 2023
- Full Text
- View/download PDF
15. Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic function
- Author
-
Zhang, Qian, Basappa, Johnvesly, Wang, Hong Y., Nunez-Cruz, Selene, Lobello, Cosimo, Wang, Shengchun, Liu, Xiaobin, Chekol, Seble, Guo, Lili, Ziober, Amy, Nejati, Reza, Shestov, Alex, Feldman, Michael, Glickson, Jerry D., Turner, Suzanne D., Blair, Ian A., Van Dang, Chi, and Wasik, Mariusz A.
- Abstract
As we show in this study, NAMPT, the key rate-limiting enzyme in the salvage pathway, one of the three known pathways involved in NAD synthesis, is selectively over-expressed in anaplastic T-cell lymphoma carrying oncogenic kinase NPM1::ALK (ALK + ALCL). NPM1::ALK induces expression of the NAMPT-encoding gene with STAT3 acting as transcriptional activator of the gene. Inhibition of NAMPT affects ALK + ALCL cells expression of numerous genes, many from the cell-signaling, metabolic, and apoptotic pathways. NAMPT inhibition also functionally impairs the key metabolic and signaling pathways, strikingly including enzymatic activity and, hence, oncogenic function of NPM1::ALK itself. Consequently, NAMPT inhibition induces cell death in vitro and suppresses ALK + ALCL tumor growth in vivo. These results indicate that NAMPT is a novel therapeutic target in ALK + ALCL and, possibly, other similar malignancies. Targeting metabolic pathways selectively activated by oncogenic kinases to which malignant cells become “addicted” may become a novel therapeutic approach to cancer, alternative or, more likely, complementary to direct inhibition of the kinase enzymatic domain. This potential therapy to simultaneously inhibit and metabolically “starve” oncogenic kinases may not only lead to higher response rates but also delay, or even prevent, development of drug resistance, frequently seen when kinase inhibitors are used as single agents.
- Published
- 2023
- Full Text
- View/download PDF
16. Impact of integrating genomic data into the electronic health record on genetics care delivery
- Author
-
Lau-Min, Kelsey S., McKenna, Danielle, Asher, Stephanie Byers, Bardakjian, Tanya, Wollack, Colin, Bleznuck, Joseph, Biros, Daniel, Anantharajah, Arravinth, Clark, Dana F., Condit, Courtney, Ebrahimzadeh, Jessica E., Long, Jessica M., Powers, Jacquelyn, Raper, Anna, Schoenbaum, Anna, Feldman, Michael, Steinfeld, Lauren, Tuteja, Sony, VanZandbergen, Christine, Domchek, Susan M., Ritchie, Marylyn D., Landgraf, Jeffrey, Chen, Jessica, and Nathanson, Katherine L.
- Abstract
Integrating genomic data into the electronic health record (EHR) is key for optimally delivering genomic medicine.
- Published
- 2022
- Full Text
- View/download PDF
17. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial
- Author
-
Osdoit, Marie, Yau, Christina, Symmans, W. Fraser, Boughey, Judy C., Ewing, Cheryl A., Balassanian, Ron, Chen, Yunn-Yi, Krings, Gregor, Wallace, Anne M, Zare, Somaye, Fadare, Oluwole, Lancaster, Rachael, Wei, Shi, Godellas, Constantine V., Tang, Ping, Tuttle, Todd M, Klein, Molly, Sahoo, Sunati, Hieken, Tina J., Carter, Jodi M., Chen, Beiyun, Ahrendt, Gretchen, Tchou, Julia, Feldman, Michael, Tousimis, Eleni, Zeck, Jay, Jaskowiak, Nora, Sattar, Husain, Naik, Arpana M., Lee, Marie Catherine, Rosa, Marilin, Khazai, Laila, Rendi, Mara H., Lang, Julie E., Lu, Janice, Tawfik, Ossama, Asare, Smita M., Esserman, Laura J., and Mukhtar, Rita A.
- Abstract
IMPORTANCE: Pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer strongly correlates with overall survival and has become the standard end point in neoadjuvant trials. However, there is controversy regarding whether the definition of pCR should exclude or permit the presence of residual ductal carcinoma in situ (DCIS). OBJECTIVE: To examine the association of residual DCIS in surgical specimens after neoadjuvant chemotherapy for breast cancer with survival end points to inform standards for the assessment of pathologic complete response. DESIGN, SETTING, AND PARTICIPANTS: The study team analyzed the association of residual DCIS after NAC with 3-year event-free survival (EFS), distant recurrence-free survival (DRFS), and local-regional recurrence (LRR) in the I-SPY2 trial, an adaptive neoadjuvant platform trial for patients with breast cancer at high risk of recurrence. This is a retrospective analysis of clinical specimens and data from the ongoing I-SPY2 adaptive platform trial of novel therapeutics on a background of standard of care for early breast cancer. I-SPY2 participants are adult women diagnosed with stage II/III breast cancer at high risk of recurrence. INTERVENTIONS: Participants were randomized to receive taxane and anthracycline-based neoadjuvant therapy with or without 1 of 10 investigational agents, followed by definitive surgery. MAIN OUTCOMES AND MEASURES: The presence of DCIS and EFS, DRFS, and LRR. RESULTS: The study team identified 933 I-SPY2 participants (aged 24 to 77 years) with complete pathology and follow-up data. Median follow-up time was 3.9 years; 337 participants (36%) had no residual invasive disease (residual cancer burden 0, or pCR). Of the 337 participants with pCR, 70 (21%) had residual DCIS, which varied significantly by tumor-receptor subtype; residual DCIS was present in 8.5% of triple negative tumors, 15.6% of hormone-receptor positive tumors, and 36.6% of ERBB2-positive tumors. Among those participants with pCR, there was no significant difference in EFS, DRFS, or LRR based on presence or absence of residual DCIS. CONCLUSIONS AND RELEVANCE: The analysis supports the definition of pCR as the absence of invasive disease after NAC regardless of the presence or absence of DCIS. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT01042379.
- Published
- 2022
- Full Text
- View/download PDF
18. Impact of fludrocortisone on the outcomes of subarachnoid hemorrhage patients: A retrospective analysis.
- Author
-
Mistry, Akshitkumar M., Naidugari, Janki, Feldman, Michael J., Magarik, Jordan A., Ding, Dale, Abecassis, Isaac J., Semler, Matthew W., and Rice, Todd W.
- Abstract
Whether the use of fludrocortisone affects outcomes of patients with aneurysmal subarachnoid hemorrhage (aSAH). We conducted a retrospective analysis of 78 consecutive patients with a ruptured aSAH at a single academic center in the United States. The primary outcome was the score on the modified Rankin scale (mRS, range, 0 [no symptoms] to 6 [death]) at 90 days. The primary outcome was adjusted for age, hypertension, aSAH grade, and time from aSAH onset to aneurysm treatment. Secondary outcomes were neurologic and cardiopulmonary dysfunction events. Among 78 patients at a single center, the median age was 58 years [IQR, 49 to 64.5]; 64 % were female, and 41 (53 %) received fludrocortisone. The adjusted common odds ratio, aOR, of a proportional odds regression model of fludrocortisone use with mRS was 0.33 (95 % CI, 0.14-0.80; P = 0.02), with values <1.0 favoring fludrocortisone. Organ-specific dysfunction events were not statistically different: delayed cerebral ischemia (22 % vs. 39 %, P = 0.16); cardiac dysfunction (0 % vs. 11 %; P = 0.10); and pulmonary edema (15 % vs. 8 %; P = 0.59). The risk of disability or death at 90 days was lower with the use of fludrocortisone in aSAH patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Examination of Standardized Letters of Recommendation Rating Scales Among Neurosurgical Residency Candidates During the 2020-2021 Application Cycle.
- Author
-
Feldman, Michael J, Ortiz, Alexander V, Roth, Steven G, Dambrino, Robert J, Yengo-Kahn, Aaron M, Chitale, Rohan V, and Chambless, Lola B
- Published
- 2021
- Full Text
- View/download PDF
20. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy
- Author
-
Peyster, Eliot G., Janowczyk, Andrew, Swamidoss, Abigail, Kethireddy, Samhith, Feldman, Michael D., and Margulies, Kenneth B.
- Published
- 2022
- Full Text
- View/download PDF
21. Machine Learning-Based Prediction of COVID-19 Severity and Progression to Critical Illness Using CT Imaging and Clinical Data.
- Author
-
Purkayastha, Subhanik, Yanhe Xiao, Zhicheng Jiao, Thepumnoeysuk, Rujapa, Halsey, Kasey, Jing Wu, Thi My Linh Tran, Ben Hsieh, Ji Whae Choi, Dongcui Wang, Vallières, Martin, Robin Wang, Collins, Scott, Xue Feng, Feldman, Michael, Zhang, Paul J., Atalay, Michael, Ronnie Sebro, Li Yang, and Yong Fan
- Published
- 2021
- Full Text
- View/download PDF
22. Arthroscopic Repair of a PASTA of the Shoulder Using a Bursal Split.
- Author
-
Manoharan, Aditya, Falgout, David, and Feldman, Michael
- Abstract
PASTA (partial articular supraspinatus tendon avulsion) lesions are a subset of partial rotator cuff tears that are commonly treated by surgeons. Multiple surgical techniques exist for managing these lesions, including debridement, transtendinous repair, and completion of the tear and repair. Each of these techniques provides its own set of advantages and disadvantages, and currently there is no consensus on which method provides the best clinical outcomes or ease of procedure. Here, we present our repair technique for PASTA lesions, which involves a bursal split that takes the advantages of previous techniques by allowing improved visualization of the footprint and suture passing while avoiding the takedown any of Sharpey's fibers. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity.
- Author
-
Arabyarmohammadi, Sara, Yuan, Cai, Viswanathan, Vidya Sankar, Lal, Priti, Feldman, Michael D., Fu, Pingfu, Margulies, Kenneth B., Madabhushi, Anant, and Peyster, Eliot G.
- Abstract
BACKGROUND: Cardiac allograft rejection is the leading cause of early graft failure and is a major focus of postheart transplant patient care. While histological grading of endomyocardial biopsy samples remains the diagnostic standard for acute rejection, this standard has limited diagnostic accuracy. Discordance between biopsy rejection grade and patient clinical trajectory frequently leads to both overtreatment of indolent processes and delayed treatment of aggressive ones, spurring the need to investigate the adequacy of the current histological criteria for assessing clinically important rejection outcomes. METHODS: N=2900 endomyocardial biopsy images were assigned a rejection grade label (high versus low grade) and a clinical trajectory label (evident versus silent rejection). Using an image analysis approach, n=370 quantitative morphology features describing the lymphocytes and stroma were extracted from each slide. Two models were constructed to compare the subset of features associated with rejection grades versus those associated with clinical trajectories. A proof-of-principle machine learning pipeline—the cardiac allograft rejection evaluator—was then developed to test the feasibility of identifying the clinical severity of a rejection event. RESULTS: The histopathologic findings associated with conventional rejection grades differ substantially from those associated with clinically evident allograft injury. Quantitative assessment of a small set of well-defined morphological features can be leveraged to more accurately reflect the severity of rejection compared with that achieved by the International Society of Heart and Lung Transplantation grades. CONCLUSIONS: Conventional endomyocardial samples contain morphological information that enables accurate identification of clinically evident rejection events, and this information is incompletely captured by the current, guideline-endorsed, rejection grading criteria. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. An Examination of Standardized Letters of Recommendation Rating Scales Among Neurosurgical Residency Candidates During the 2020-2021 Application Cycle
- Author
-
Feldman, Michael J, Ortiz, Alexander V, Roth, Steven G, Dambrino, Robert J, Yengo-Kahn, Aaron M, Chitale, Rohan V, and Chambless, Lola B
- Published
- 2021
- Full Text
- View/download PDF
25. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial
- Author
-
Symmans, W. Fraser, Yau, Christina, Chen, Yunn-Yi, Balassanian, Ron, Klein, Molly E., Pusztai, Lajos, Nanda, Rita, Parker, Barbara A., Datnow, Brian, Krings, Gregor, Wei, Shi, Feldman, Michael D., Duan, Xiuzhen, Chen, Beiyun, Sattar, Husain, Khazai, Laila, Zeck, Jay C., Sams, Sharon, Mhawech-Fauceglia, Paulette, Rendi, Mara, Sahoo, Sunati, Ocal, Idris Tolgay, Fan, Fang, LeBeau, Lauren Grasso, Vinh, Tuyethoa, Troxell, Megan L., Chien, A. Jo, Wallace, Anne M., Forero-Torres, Andres, Ellis, Erin, Albain, Kathy S., Murthy, Rashmi K., Boughey, Judy C., Liu, Minetta C., Haley, Barbara B., Elias, Anthony D., Clark, Amy S., Kemmer, Kathleen, Isaacs, Claudine, Lang, Julie E., Han, Hyo S., Edmiston, Kirsten, Viscusi, Rebecca K., Northfelt, Donald W., Khan, Qamar J., Leyland-Jones, Brian, Venters, Sara J., Shad, Sonal, Matthews, Jeffrey B., Asare, Smita M., Buxton, Meredith, Asare, Adam L., Rugo, Hope S., Schwab, Richard B., Helsten, Teresa, Hylton, Nola M., van ’t Veer, Laura, Perlmutter, Jane, DeMichele, Angela M., Yee, Douglas, Berry, Donald A., and Esserman, Laura J.
- Abstract
IMPORTANCE: Residual cancer burden (RCB) distributions may improve the interpretation of efficacy in neoadjuvant breast cancer trials. OBJECTIVE: To compare RCB distributions between randomized control and investigational treatments within subtypes of breast cancer and explore the relationship with survival. DESIGN, SETTING, AND PARTICIPANTS: The I-SPY2 is a multicenter, platform adaptive, randomized clinical trial in the US that compares, by subtype, investigational agents in combination with chemotherapy vs chemotherapy alone in adult women with stage 2/3 breast cancer at high risk of early recurrence. Investigational treatments graduated in a prespecified subtype if there was 85% or greater predicted probability of higher rate of pathologic complete response (pCR) in a confirmatory, 300-patient, 1:1 randomized, neoadjuvant trial in that subtype. Evaluation of a secondary end point was reported from the 10 investigational agents tested in the I-SPY2 trial from March 200 through 2016, and analyzed as of September 9, 2020. The analysis plan included modeling of RCB within subtypes defined by hormone receptor (HR) and ERBB2 status and compared control treatments with investigational treatments that graduated and those that did not graduate. INTERVENTIONS: Neoadjuvant paclitaxel plus/minus 1 of several investigational agents for 12 weeks, then 12 weeks of cyclophosphamide/doxorubicin chemotherapy followed by surgery. MAIN OUTCOMES AND MEASURES: Residual cancer burden (pathological measure of residual disease) and event-free survival (EFS). RESULTS: A total of 938 women (mean [SD] age, 49 [11] years; 66 [7%] Asian, 103 [11%] Black, and 750 [80%] White individuals) from the first 10 investigational agents were included, with a median follow-up of 52 months (IQR, 29 months). Event-free survival worsened significantly per unit of RCB in every subtype of breast cancer (HR-positive/ERBB2-negative: hazard ratio [HZR], 1.75; 95% CI, 1.45-2.16; HR-positive/ERBB2-positive: HZR, 1.55; 95% CI, 1.18-2.05; HR-negative/ERBB2-positive: HZR, 2.39; 95% CI, 1.64-3.49; HR-negative/ERBB2-negative: HZR, 1.99; 95% CI, 1.71-2.31). Prognostic information from RCB was similar from treatments that graduated (HZR, 2.00; 95% CI, 1.57-2.55; 254 [27%]), did not graduate (HZR, 1.87; 95% CI, 1.61-2.17; 486 [52%]), or were control (HZR, 1.79; 95% CI, 1.42-2.26; 198 [21%]). Investigational treatments significantly lowered RCB in HR-negative/ERBB2-negative (graduated and nongraduated treatments) and ERBB2-positive subtypes (graduated treatments), with improved EFS (HZR, 0.61; 95% CI, 0.41-0.93) in the exploratory analysis. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, the prognostic significance of RCB was consistent regardless of subtype and treatment. Effective neoadjuvant treatments shifted the distribution of RCB in addition to increasing pCR rate and appeared to improve EFS. Using a standardized quantitative method to measure response advances the interpretation of efficacy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01042379
- Published
- 2021
- Full Text
- View/download PDF
26. A 15-Year Review of Iatrogenic Burn Injuries in an Academic Public Hospital
- Author
-
Andersen, Emily S, Powell, Lauren E, Marcaccini, Robert L, Feldman, Michael J, and Drake, Mack D
- Abstract
Hospital-acquired burn injuries can result in increased length of hospitalization, costs of stay, and potential for additional procedures. The aim of this study was to describe iatrogenic burn injuries over a 15-year period at an academic public hospital system. Data was collected from January 2004 to June 2019. Data included time of injury, hospital location, mechanism, level of harm caused, and anatomic location of the injury. Demographic information included patient age, gender, body mass index, payer status, primary admission diagnosis and length of stay. 122 patients were identified through an internal hospital database that tracked reported injuries. Incidence was highest between 2005–2012 (12.3 ± 4.1 per year) when compared with 2013–2019 (2.9 ± 2.1 per year). A majority (77%) resulted in harm caused to the patient. Most (41%) of the injuries occurred on the general medical floors, followed by the operating room (33.6%). The most common etiology was scald (23%), followed by electrocautery (14.8%). Five of the injuries resulted in burn consults, although none of these patients required surgery. Iatrogenic burns appear to be decreasing. While a majority were reported to have caused patient harm, none were serious enough to warrant surgery. Most injuries occurred on the medical floors with a scald mechanism. This review presents an opportunity to emphasize in-hospital burn prevention, as well as an opportunity for the burn team to affect change in concert with hospital administration.
- Published
- 2021
- Full Text
- View/download PDF
27. Evaluation of COVID-19 Testing Strategies for Repopulating College and University Campuses: A Decision Tree Analysis.
- Author
-
Van Pelt, Amelia, Glick, Henry A., Yang, Wei, Rubin, David, Feldman, Michael, and Kimmel, Stephen E.
- Abstract
The optimal approach to identify SARS-CoV-2 infection among college students returning to campus is unknown. Recommendations vary from no testing to two tests per student. This research determined the strategy that optimizes the number of true positives and negatives detected and reverse transcription polymerase chain reaction (RT-PCR) tests needed. A decision tree analysis evaluated five strategies: (1) classifying students with symptoms as having COVID-19, (2) RT-PCR testing for symptomatic students, (3) RT-PCR testing for all students, (4) RT-PCR testing for all students and retesting symptomatic students with a negative first test, and (5) RT-PCR testing for all students and retesting all students with a negative first test. The number of true positives, true negatives, RT-PCR tests, and RT-PCR tests per true positive (TTP) was calculated. Strategy 5 detected the most true positives but also required the most tests. The percentage of correctly identified infections was 40.6%, 29.0%, 53.7%, 72.5%, and 86.9% for Strategies 1–5, respectively. All RT-PCR strategies detected more true negatives than the symptom-only strategy. Analysis of TTP demonstrated that the repeat RT-PCR strategies weakly dominated the single RT-PCR strategy and that the thresholds for more intensive RT-PCR testing decreased as the prevalence of infection increased. Based on TTP, the single RT-PCR strategy is never preferred. If the cost of RT-PCR testing is of concern, a staged approach involving initial testing of all returning students followed by a repeat testing decision based on the measured prevalence of infection might be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
28. Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity
- Author
-
Arabyarmohammadi, Sara, Yuan, Cai, Viswanathan, Vidya Sankar, Lal, Priti, Feldman, Michael D., Fu, Pingfu, Margulies, Kenneth B., Madabhushi, Anant, and Peyster, Eliot G.
- Published
- 2024
- Full Text
- View/download PDF
29. Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study.
- Author
-
Zamarin, Dmitriy, Burger, Robert A., Sill, Michael W., Powell, Daniel J., Lankes, Heather A., Feldman, Michael D., Zivanovic, Oliver, Gunderson, Camille, Ko, Emily, Mathews, Cara, Sharma, Sudarshan, Hagemann, Andrea R., Khleif, Samir, and Aghajanian, Carol
- Published
- 2020
- Full Text
- View/download PDF
30. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models
- Author
-
Froehler, Michael T, Feldman, Michael J, Poitras, Bryan, and Daniels, Anthony B
- Abstract
BackgroundThe New Zealand White rabbit (NZWR) is the first small-animal experimental model of intra-arterial chemotherapy (IAC) for retinoblastoma treatment. The NZWR has dual ophthalmic arteries (OA): the external OA (EOA) arises from the external carotid artery and the internal OA (IOA) from the internal carotid artery. We describe the technique that we have refined for OA catheterization in rabbits, and describe the angioanatomical variations in the OA supply to the NZWR eye and implications for IAC delivery, which were identified as part of a larger project exploring IAC effects in a rabbit retinoblastoma model.MethodsWe developed techniques to perform angiography of the external and internal carotid arteries and superselective angiography of the EOA and IOA in NZWR using transfemoral access and a microwire/microcatheter system. EOA and IOA supply to the eye was determined angiographically and recorded before selective OA catheterization and angiography.Results114 rabbits underwent carotid angiographic evaluation and OA catheterization (161 total eyes evaluated, 112 right, 49 left). Most eyes had a single dominant arterial supply; either IOA or EOA. EOA was dominant in 73% (118/161), and IOA was dominant in 17% (27/161). Co-dominant supply was seen in 10% (16/161). Of the rabbits with bilateral OA catheterization, 25/47 (53%) had bilateral dominant EOA.ConclusionSuccessful catheterization of the OA in the NZWR can be readily accomplished with nuanced technique. The external OA is the dominant arterial supply in the majority of NZWR eyes. These findings allow for successful reproduction of OA catheterization studies of IAC for retinoblastoma in NZWR.
- Published
- 2021
- Full Text
- View/download PDF
31. Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomes
- Author
-
Feldman, Michael J, Roth, Steven, Fusco, Matthew R, Mehta, Tapan, Arora, Niraj, Siegler, James E, Schrag, Matthew, Mittal, Shilpi, Kirshner, Howard, Mistry, Akshitkumar M., Yaghi, Shadi, Chitale, Rohan V, Khatri, Pooja, and Mistry, Eva A
- Abstract
BackgroundIntracerebral hemorrhage (ICH) occurs in ~20%–30% of stroke patients undergoing endovascular therapy (EVT). However, there is conflicting evidence regarding the effect of asymptomatic ICH (aICH) on post-EVT outcomes. We sought to evaluate the effect of aICH on immediate and 90-day post-EVT neurological outcomes.MethodsIn this post-hoc analysis of the multicenter, prospective Blood Pressure after Endovascular Therapy (BEST) study we identified subjects with ICH following EVT. This population was divided into no ICH, aICH, and symptomatic ICH (sICH). Associations with 90-day modified Rankin Scale (mRS) dichotomized by functional independence (0–2 vs 3–6) and early neurological recovery (ENR) were determined using univariate/multivariate logistic regression models.ResultsOf 485 patients enrolled in BEST, 446 had 90-day follow-up data available. 92 (20.6%) developed aICH, and 18 (4%) developed sICH. Compared with those without ICH, aICH was not associated with worse 90-day outcome or lower ENR (OR 0.84 [0.53–1.35], P=0.55, aOR 0.84 [0.48–1.44], P=0.53 for 90-day mRS 0–2; OR 0.77 [0.48–1.23], P=0.34, aOR 0.72 [0.43–1.22] for ENR). aICH was not associated with 90-day outcome or ENR in patients with mTICI ≥2 b (OR 0.78 [0.48–1.26], P=0.33 for 90-day mRS 0–2; OR 0.89 [0.69–1.12], P=0.15 for ENR). A higher proportion of patients with aICH had mTICI ≥2 b than those without ICH (97%vs 87%, P=0.01).ConclusionsaICH was not associated with worse outcomes in patients with large-vessel stroke treated with EVT. aICH was more frequent in patients with successful recanalization. Further validation of our findings in large cohort studies of EVT-treated patients is warranted.
- Published
- 2021
- Full Text
- View/download PDF
32. A Penny for the Baker: Raisin Bread's Simple Secrets.
- Author
-
FELDMAN, MICHAEL
- Subjects
RAISINS ,BREAD - Published
- 2021
33. Editorial Commentary: Suture Button-Anchor Fixation Is Preferable to Hook Plate Fixation for Acute Acromioclavicular Joint Dislocations: Form and Function Need to Be United.
- Author
-
Feldman, Michael D.
- Abstract
Both hook plate fixation and suture button-anchor fixation have been reported to yield good results in the treatment of acute acromioclavicular joint reconstruction. In addition to a mandatory secondary procedure, hook plate fixation clearly has an increased prevalence of post-traumatic acromioclavicular arthritis in the short term that is likely to progress in the long term. Conversely, suture button-anchor fixation-a minimally invasive technique that creates less soft-tissue disruption, does not require hardware removal, and does not violate the acromioclavicular joint-is more likely to promote primary healing of the coracoclavicular ligaments, reduce the risk of late displacement, and minimize the development of post-traumatic acromioclavicular arthritis. As stated by the noted architect Frank Lloyd Wright, it is not only about form (i.e., alignment), it is about function as well. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
34. COVID-19: What paramedics need to know!
- Author
-
Buick, Jason E., Cheskes, Sheldon, Feldman, Michael, Verbeek, P. Richard, Hillier, Morgan, Leong, Yuen Chin, and Drennan, Ian R.
- Published
- 2020
- Full Text
- View/download PDF
35. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction
- Author
-
Vaidya, Pranjal, Bera, Kaustav, Gupta, Amit, Wang, Xiangxue, Corredor, Germán, Fu, Pingfu, Beig, Niha, Prasanna, Prateek, Patil, Pradnya D, Velu, Priya D, Rajiah, Prabhakar, Gilkeson, Robert, Feldman, Michael D, Choi, Humberto, Velcheti, Vamsidhar, and Madabhushi, Anant
- Abstract
Use of adjuvant chemotherapy in patients with early-stage lung cancer is controversial because no definite biomarker exists to identify patients who would receive added benefit from it. We aimed to develop and validate a quantitative radiomic risk score (QuRiS) and associated nomogram (QuRNom) for early-stage non-small cell lung cancer (NSCLC) that is prognostic of disease-free survival and predictive of the added benefit of adjuvant chemotherapy following surgery.
- Published
- 2020
- Full Text
- View/download PDF
36. Research Pearls: How Do We Establish the Level of Evidence?
- Author
-
Hohmann, Erik, Feldman, Michael, Hunt, Timothy J, Cote, Mark P, and Brand, Jefferson C
- Abstract
Evidence-based medicine (EBM) guidelines were first introduced in 1986 and were defined as the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients. The practice of EBM means integrating individual clinical expertise with the best available external clinical evidence from systematic research. Level of evidence (LOE) stratifies publications from Level I to Level V and provides the foundation for EBM. Three questions should be asked when an LOE is assigned to a scientific article: (1) What is the research question? (2) What is the study type? and (3) What is the hierarchy of evidence? In cases in which LOE is not appropriate or relevant (basic science and laboratory-based investigations), a clinical relevance statement should be used. Unfortunately, study quality is not assessed by the assigned hierarchy level. LOE and EBM have increased the number of investigations published with better levels of evidence. As authors, reviewers, editors, and publishers, we desire a system that is consistent, effective, and reliable. Fortunately, the system has proven to have all of those attributes with good interobserver and intra-observer values. The increase in investigations with higher LOEs allows for more frequent use of EBM. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
37. Sinonasal Undifferentiated Carcinoma (SNUC) in a Patient with Pituitary Prolactinoma and Metastatic Pancreatic Carcinoma: A Case Report and Review of the Literature
- Author
-
Chi, John J., Feldman, Michael D., and Palmer, James N.
- Published
- 2024
- Full Text
- View/download PDF
38. Angiographic analysis of ophthalmic artery flow direction in children undergoing chemosurgery for retinoblastoma compared to age-matched controls
- Author
-
Feldman, Michael, Grimaudo, Heather, Roth, Steven, Mummareddy, Nishit, Vance, Haley, Daniels, Anthony B, and Froehler, Michael T
- Abstract
Purpose Catheter-based intra-arterial chemotherapy (IAC) has revolutionized the treatment of retinoblastoma (RB). Variability in ophthalmic artery (OA) flow, either retrograde from external carotid artery branches, or anterograde from the internal carotid artery, necessitates multiple IAC techniques. We evaluated the direction of OA flow and identify OA flow reversal events over the course of IAC treatment as well in comparison to OA flow direction in non-RB children.Materials and Methods We performed a retrospective analysis of OA flow direction in all RB patients treated with IAC, along with an age-matched control group who underwent cerebral angiography at our center from 2014 to 2020.Results IAC was administered to a total of 18 eyes (15 patients). Initial anterograde OA flow was demonstrated in 66% (n= 12) of eyes. Five OA reversal events were identified (3/5 anterograde-to-retrograde). All five events were in patients receiving multiagent chemotherapy. No correlation was found between OA flow reversal events and the initial IAC technique. A control group of 88 angiograms representing 82 eyes (41 patients) was utilized. The anterograde flow was observed in 76 eyes (86.4%). Our control group included 19 patients with sequential angiograms. One OA flow reversal event was identified.Conclusion OA flow direction is dynamic in IAC patients. Anterograde and retrograde OA directional switches do occur and may necessitate delivery technique variation. In our analysis, all OA flow reversal events were associated with multiagent chemotherapy regimens. Both anterograde and retrograde OA flow patterns were observed in our control cohort, suggesting bidirectional flow can occur in non-RB children.
- Published
- 2024
- Full Text
- View/download PDF
39. Flat-panel dual-energy head computed tomography in the angiography suite after thrombectomy for acute stroke: A clinical feasibility study
- Author
-
DiNitto, Julie, Feldman, Michael, Grimaudo, Heather, Mummareddy, Nishit, Ahn, Seoiyoung, Bhamidipati, Akshay, Anderson, Drew, Ramirez-Giraldo, Juan Carlos, Fusco, Matthew, Chitale, Rohan, and Froehler, Michael T
- Abstract
Background Management of large vessel occlusion (LVO) patients after thrombectomy is affected by the presence of intracranial hemorrhage (ICH) on post-procedure imaging. Differentiating contrast staining from hemorrhage on post-procedural imaging has been facilitated by dual-energy computed tomography (DECT), traditionally performed in dedicated computed tomography (CT) scanners with subsequent delays in treatment. We employed a novel method of DECT using the Siemens cone beam CT (DE-CBCT) in the angiography suite to evaluate for post-procedure ICH and contrast extravasation.Methods After endovascular treatment for LVO was performed and before the patient was removed from the operating table, DE-CBCT was performed using the Siemens Q-biplane system, with two separate 20-second CBCT scans at two energy levels: 70 keV (standard) and 125 keV with tin filtration (nonstandard). Post-procedurally, patients also underwent a standard DECT using Siemens SOMATOM Force CT scanner. Two independent reviewers blindly evaluated the DE-CBCT and DECT for hemorrhage and contrast extravasation.Results We successfully performed intra-procedural DE-CBCT in 10 subjects with no technical failure. The images were high-quality and subjectively useful to differentiate contrast from hemorrhage. The one hemorrhage seen on standard DECT was very small and clinically silent. The interrater reliability was 100% for both contrast and hemorrhage detection.Conclusion We demonstrate that intra-procedural DE-CBCT after thrombectomy is feasible and provides clinically meaningful images. There was close agreement between findings on DE-CBCT and standard DECT. Our findings suggest that DE-CBCT could be used in the future to improve stroke thrombectomy patient workflow and to more efficiently guide the postoperative management of these patients.
- Published
- 2024
- Full Text
- View/download PDF
40. Injuries in the Chinese Arena Football League: American Versus Chinese Players.
- Author
-
Tianwu Chen, Wetzler, Austin, Singer, Scott, Feldman, Michael, Rubenstein, David, Gillespie, Gunnar, Shiyi Chen, and Wetzler, Merrick
- Published
- 2018
- Full Text
- View/download PDF
41. Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapy.
- Author
-
Ahn, Peter H., Finlay, Jarod C., Gallagher-Colombo, Shannon M., Quon, Harry, JrO’Malley, Bert W., Weinstein, Gregory S., Chalian, Ara, Malloy, Kelly, Sollecito, Thomas, Greenberg, Martin, IISimone, Charles B., McNulty, Sally, Lin, Alexander, Zhu, Timothy C., Livolsi, Virginia, Feldman, Michael, Mick, Rosemarie, Cengel, Keith A., and Busch, Theresa M.
- Abstract
Background We report on a Phase 1 trial of photodynamic therapy (PDT) for superficial head and neck (H&N) lesions. Due to known oxygen dependencies of PDT, translational measurements of lesion hemoglobin oxygen saturation (S t O 2 ) and blood volume (tHb) were studied for associations with patient outcomes. Methods PDT with aminolevulinc acid (ALA) and escalating light doses was evaluated for high-grade dysplasia, carcinoma-in-situ, and microinvasive carcinomas of the H&N. Among 29 evaluable patients, most (18) had lesions of the tongue or floor of mouth (FOM). Disease was intact in 18 patients and present at surgical margins in 11 patients. In 26 patients, lesion S t O 2 and tHb was measured. Results Local control (LC) at 24 months was 57.5% among all patients. In patients with tongue/FOM lesions LC was 42.7%, and it was 50.1% for those with intact lesions. Lesion tHb was not associated with 3-month complete response (CR), but S t O 2 was higher in patients with CR. In tongue/FOM lesions, baseline S t O 2 [mean(SE)] was 54(4)% in patients (n = 12) with CR versus 23(8)% in patients (n = 6) with local recurrence/persistence (p = 0.01). Similarly, for intact disease, baseline S t O 2 was 54(3)% in patients (n = 10) with CR versus 28(8)% in patients (n = 5) without CR (p = 0.03). In patients with intact disease, higher baseline S t O 2 associated with 24-month local control (p = 0.02). Conclusions Measurement of the physiologic properties of target lesions may allow for identification of patients with the highest probability of benefiting from PDT. This provides opportunity for optimizing light delivery based on lesion characteristics and/or informing ongoing clinical decision-making in patients who would most benefit from PDT. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
42. Improving Temporal Trends in Survival and Neurological Outcomes After Out-of-Hospital Cardiac Arrest.
- Author
-
Buick, Jason E., Drennan, Ian R., Scales, Damon C., Brooks, Steven C., Byers, Adam, Cheskes, Sheldon, Dainty, Katie N., Feldman, Michael, Verbeek, P. Richard, Zhan, Cathy, Kiss, Alex, Morrison, Laurie J., Lin, Steve, Byers, Adams, and Rescu Investigators
- Abstract
Background: Considerable effort has gone into improving outcomes from out-of-hospital cardiac arrest (OHCA). Studies suggest that survival is improving; however, prior studies had insufficient data to pursue the relationship between markers of guideline compliance and temporal trends. The objective of the study was to evaluate trends in OHCA survival over an 8-year period that included the implementation of the 2005 and 2010 international cardiopulmonary resuscitation (CPR) guidelines.Methods and Results: This was a population-based cohort study of all consecutive treated OHCA patients of presumed cardiac cause between 2006 and 2013 in the City of Toronto, Canada, and surrounding regions. Temporal changes were measured by χ2 trend test. The association between year of the OHCA and survival was evaluated using logistic regression and joinpoint analysis. A total of 23 619 patients with OHCA met study inclusion criteria. During the study period, survival to hospital discharge doubled (4.8% in 2006 to 9.4% in 2013; P<0.0001), and survival with good neurological outcome increased (6.2% in 2010 to 8.5% in 2013; P=0.005). Improvements occurred in the rates of bystander CPR and automated external defibrillator application, high-quality CPR metrics, and in-hospital targeted temperature management. After adjusting for the Utstein variables, survival to hospital discharge (odds ratio, 1.12; 95% confidence interval, 1.09-1.15) and survival with good neurological outcome (odds ratio, 1.13; 95% confidence interval, 1.05-1.22) increased with each year of study.Conclusions: Survival after OHCA has improved over time. This trend was associated with improved rates of bystander CPR, automated external defibrillator use, high-quality CPR metrics, and in-hospital targeted temperature management. The results suggest that multiple factors, each improving over time, may have contributed to the observed increase in survival. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
43. Biguanides enhance antifungal activity against Candida glabrata
- Author
-
Xu, Shuying, Feliu, Marianela, Lord, Allison K., Lukason, Daniel P., Negoro, Paige E., Khan, Nida S., Dagher, Zeina, Feldman, Michael B., Reedy, Jennifer L., Steiger, Samantha N., Tam, Jenny M., Soukas, Alexander A., Sykes, David B., and Mansour, Michael K.
- Abstract
ABSTRACTCandida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabratais the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of metformin, a biguanide with well-established action for diabetes, as an antifungal agent against C. glabrata. Both wild type and antifungal-resistant isolates of C. glabratawere subjected to biguanide and biguanide-antifungal combination treatment. Metformin, as well as other members of the biguanide family, were found to have antifungal activity against C. glabrata, with MIC50of 9.34 ± 0.16 mg/mL, 2.09 ± 0.04 mg/mL and 1.87 ± 0.05 mg/mL for metformin, phenformin and buformin, respectively. We demonstrate that biguanides enhance the activity of several antifungal drugs, including voriconazole, fluconazole, and amphotericin, but not micafungin. The biguanide-antifungal combinations allowed for additional antifungal effects, with fraction inhibition concentration indexes ranging from 0.5 to 1. Furthermore, metformin was able to lower antifungal MIC50in voriconazole and fluconazole-resistant clinical isolates of C. glabrata. We also observed growth reduction of C. glabratawith rapamycin and an FIC of 0.84 ± 0.09 when combined with metformin, suggesting biguanide action in C. glabratamay be related to inhibition of the mTOR complex. We conclude that the biguanide class has direct antifungal therapeutic potential and enhances the activity of select antifungals in the treatment of resistant C. glabrataisolates. These data support the further investigation of biguanides in the combination treatment of serious fungal infections.
- Published
- 2018
- Full Text
- View/download PDF
44. Discussion of ‘Ending Analysis: The Case of Karl’
- Author
-
Feldman, Michael
- Published
- 2018
- Full Text
- View/download PDF
45. Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative
- Author
-
Lau-Min, Kelsey S., Asher, Stephanie Byers, Chen, Jessica, Domchek, Susan M., Feldman, Michael, Joffe, Steven, Landgraf, Jeffrey, Speare, Virginia, Varughese, Lisa A., Tuteja, Sony, VanZandbergen, Christine, Ritchie, Marylyn D., and Nathanson, Katherine L.
- Published
- 2021
- Full Text
- View/download PDF
46. Editorial Commentary: Magnetic Resonance Imaging Is Helpful in Predicting High-Grade Knee Rotatory Instability: But When in Doubt, Always Examine the Patient.
- Author
-
Feldman, Michael D.
- Abstract
Unrecognized rotatory instability as evidenced by a high-grade pivot shift is well known to compromise anterior cruciate ligament (ACL) reconstruction results. By measuring which patients have anterior tibial subluxation of the lateral compartment ≥ 6 mm on a preoperative MRI, surgeons may be better able to counsel patients on postoperative expectations, as well as prepare for additional procedures to treat high-grade rotatory instability. Additionally, as there is an increased incidence of lateral meniscus tears in high-grade rotatory ACL lesions, surgeons should be vigilant and prepared to repair lateral meniscus root and ramp lesions. Furthermore, early identification of those patients with anterior tibial subluxation of the lateral compartment ≥6 mm will provide the opportunity for early surgery, as it is known that patients with high-grade rotatory instability are likely to sustain further intra-articular damage and have poorer outcomes if surgery is delayed. However, when there is doubt of high-grade rotatory instability after an ACL injury, examining the patient with a pivot shift maneuver should still be the "gold standard". [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
47. Editorial Commentary: Free Bone Block With Remplissage Provides Less Translation Than Free Bone Block Alone in Shoulder Instability Patients With Bipolar Bone Loss.
- Author
-
Feldman, Michael D.
- Abstract
It would stand to reason that, in shoulder instability patients with bipolar bone loss, the combination of a bone block procedure and a remplissage procedure would provide better results than each one alone. Why would this be the case? When performing these procedures in the lateral decubitus position for patients with critical bipolar bone loss, the humeral head is anteriorly and inferiorly subluxed. This is most likely due to the incompetent restraints when in traction. A bone block procedure alone doesn't necessarily reduce the glenohumeral center of rotation; rather, it increases the "jump distance," making it more difficult for the humerus to dislocate over the bone block. However, the remplissage procedure not only makes the Hill-Sachs lesion extra-articular and prevents the defect from levering out the humerus, but also seems to pull the humeral head posteriorly centering it in the glenoid. This provides a posterior tether to the humeral head while increasing the jump distance over the bone block even further. In the future, one can anticipate a significant increase in remplissage-augmented bone block procedures in patients with bipolar bone loss. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
48. Editorial Commentary: Indications for Shoulder SLAP Lesion Repair Versus Biceps Tenodesis Depend on Patient Age, Tear Type and Location, and Quality of Tissue.
- Author
-
Feldman, Michael D.
- Abstract
Whether to repair a shoulder SLAP lesion or perform a biceps tenodesis depends on a multitude of factors: patient age, activity or work level, type of SLAP tear, location of SLAP tear, and quality of labral tissue. Determining which procedure to perform does not have such a simple, one-size-fits-all solution. For patients younger than 40 years, repair of type 2 SLAP tears that do not directly affect the biceps anchor (i.e., those tears from the 12:30 clock-face position to the 2-o'clock position or from the 10-o'clock position to the 11:30 clock-face position) is generally successful. For tears at the biceps anchor in patients younger than 40 years, repair the SLAP tear but perform tenodesis of the biceps. For type 3 SLAP tears, debride the bucket-handle component and spare the biceps because it usually is not involved. For type 4 tears, perform tenodesis. In patients older than 40 years, type 2 and type 4 SLAP tears are predominantly treated with biceps tenodesis with debridement of the SLAP tear, if indicated. SLAP repair is rarely indicated in patients older than 40 years because the tissue is usually degenerative and frayed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. Push-Alert Notification of Troponin Results to Physician Smartphones Reduces the Time to Discharge Emergency Department Patients: A Randomized Controlled Trial.
- Author
-
Verma, Aikta, Wang, Angela S., Feldman, Michael J., Hefferon, Darren A., Kiss, Alex, and Lee, Jacques S.
- Subjects
CHEST pain ,CLINICAL medicine ,COMPARATIVE studies ,LENGTH of stay in hospitals ,HOSPITAL emergency services ,INFORMATION storage & retrieval systems ,MEDICAL databases ,RESEARCH methodology ,MEDICAL cooperation ,PHYSICIANS ,QUALITY assurance ,RESEARCH ,TIME ,EVALUATION research ,RANDOMIZED controlled trials ,DISCHARGE planning ,RETROSPECTIVE studies ,SEVERITY of illness index ,TROPONIN - Abstract
Study Objective: For emergency department (ED) patients with chest pain, discharge decisions often hinge on troponin results. Push-alert notifications deliver results immediately to physician smartphones. Our objective is to determine whether troponin push alerts improve the time to discharge decisions for ED patients with chest pain.Methods: In an academic ED, we assessed the effect of a quality improvement initiative using troponin push alerts to physician smartphones, with a cluster-randomized evaluation. Participating physicians were randomized to receive troponin push alerts (intervention) or not receive them (control). We retrospectively identified patients treated by participating physicians during the study period who were discharged from the ED with chest pain. The primary outcome was the time from final troponin result to discharge decision. Secondary outcomes included length of stay. A linear mixed model was used to adjust for physician clustering.Results: During the study, 1,554 patients were discharged from the ED with chest pain. There were 551 patients in the control group and 554 in the intervention group who met inclusion criteria. The overall median interval from final troponin result to discharge decision was 79.7 minutes (interquartile range [IQR] 33.6 to 167.8 minutes); it was 94.3 minutes (IQR 36.2 to 177.8 minutes) in the control group and 68.5 minutes (IQR 30.5 to 157.2 minutes) in the intervention group. This 25.8-minute difference in medians (95% confidence interval 24.6 to 28.0 minutes) was statistically significant. Total ED length of stay was 345 minutes (IQR 261 to 419 minutes) in the control group and 328 minutes (IQR 250 to 408 minutes) in the intervention group.Conclusion: Physicians who received troponin push alerts discharged their patients with chest pain 26 minutes faster than those without troponin notifications. Total ED length of stay did not significantly improve for these patients. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
50. Seizures and Rashes Do Run in the Family.
- Author
-
Hochberg, Amit, Foldi, Sylvia, Nadir, Erez, Shreter, Roni, Mahajnah, Muhammad, and Feldman, Michael
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.